Richie Sapp, who began working in the Shatz lab as an undergraduate, was co-first author on a paper in the esteemed journal Science Translational Medicine, describing the role that the PirB protein plays in preventing the formation of new connections between neurons. The team developed a decoy drug that allowed mice to form new connections as adults, leading to findings that could eventually help people recover from stroke, forms of blindness and Alzheimer's disease.
Read more about Sapp's project - and others funded by undergraduate research grants - here: http://stanford.io/1wZtk6R